BioStem Technologies Shines at SAWC Spring Meeting with Innovative Collaborations
Pompano Beach, FL – May 1, 2025 (GLOBE NEWSWIRE) – BioStem Technologies, Inc. (OTC: BSEM), a front-runner in placental-derived products for advanced wound care, is set to showcase its innovations at the Symposium for Advanced Wound Care (SAWC) Spring meeting in Dallas, TX, from April 30 to May 4. The company will co-exhibit with partner Venture Medical, LLC, emphasizing their combined efforts in chronic wound care management.
At the event, BioStem will highlight its premier allografts, AmnioWrap2® and Vendaje AC®, exclusively distributed through Venture Medical. The collaboration aims to enhance patient management through the Venture OneView™ platform, which simplifies the treatment logistics for chronic wound patients, streamlining insurance verification and compliance processes.
“Our partnership underscores important advancements in chronic wound care,” stated Jason Matuszewski, CEO of BioStem. “The integration of our products with Venture Medical enables healthcare providers to manage patient care effectively.”
The agenda includes presentations on various topics, such as evolving reimbursement landscapes and mobile wound care practices, along with engaging interactions at their booth. Notably, BioStem will present three accepted scientific posters, showcasing the efficacy of its BioREtain® technology in managing diabetic foot ulcers.
Dr. Wendy Weston, BioStem’s VP of Research and Development, remarked, “These presentations will demonstrate favorable outcomes with our allograft products compared to competitors.” The company is also engaged in ongoing clinical trials to further validate its advancements.
As experts gather to discuss the future of wound care, BioStem aims to make significant contributions to the field, solidifying its reputation as an innovator in wound management.
For further updates and insights, follow BioStem on their social media platforms.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
